New drug combo tested for Tough-to-Treat lung cancer
NCT ID NCT07414953
Summary
This early-stage study is testing a new combination therapy called HS-10504 for people with advanced non-small cell lung cancer that has continued to grow despite previous treatments. The main goals are to find the safest and most effective dose and to see how well the body handles the drug. Researchers will enroll about 400 participants to check for side effects and see if the treatment helps shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.